Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PegBio CoHKSE:02565 +23.59%11 Gross Margin % is 0.00% as of Dec. 2025. GuruFocus rates HKSE:02565 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 734 Biotechnology companies, PegBio Co ranks worse than 136239.65% on this metric.
The historical rank and industry rank for PegBio Co's Gross Margin % or its related term are showing as below:
HKSE:02565's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 60.69 * Ranked among companies with meaningful Gross Margin % only.
PegBio Co had a gross margin of N/A% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for PegBio Co was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
PegBio Co had a gross margin of N/A% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
PegBio Co Gross Margin % Related Terms
PegBio Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for PegBio Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02565 vs VRTX, REGN, RVMD: Gross Margin % Comparison
For the Biotechnology subindustry, PegBio Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PegBio Co Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PegBio Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where PegBio Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
PegBio Co (HKSE:02565) has a Gross Margin % of 0.00% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on PegBio Co and its competitors. According to the industry distribution chart, PegBio Co ranks #999999 out of 734 companies in the Biotechnology industry.
Is PegBio Co's Gross Margin % too high?
PegBio Co's current Gross Margin % is 0.00%. Based on the distribution chart, PegBio Co ranks #999999 out of 734 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PegBio Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does PegBio Co's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PegBio Co ranks #999999 out of 734 companies for Gross Margin %. This places PegBio Co in the lower half of its industry. The industry median Gross Margin % is 60.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.69, based on 734 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on PegBio Co and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PegBio Co's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PegBio Co stock overvalued right now?
PegBio Co (HKSE:02565) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. PegBio Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For PegBio Co (HKSE:02565), the current Gross Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PegBio Co Ltd is engaged in the discovery and development of therapies. The company's main product PB-119, is a self-developed, obtained marketing approval from the National Medical Products Administration (NMPA) and entered commercialization preparation stage, long-acting glucagonlike peptide 1 (GLP-1, a peptide hormone that decreases blood sugar levels) receptor agonist. The Company's product candidates include PB-718, PB-1902, PB-722, PB-2301 and PB-2309.
11GF Score
Get the complete analysis for HKSE:02565
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02565 has been successfully added to your 
